Vancomycin Oral Capsule
Vancomycin Oral Capsule is a pharmaceutical drug with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Antibiotics and Vaccine Immune Responses Study
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Clinical Trials (7)
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Antibiotics and Vaccine Immune Responses Study
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Clostridioides Difficile Colonisation
Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7